Drugs / Autologous Stem Cells (CD34+)
last change Dec 2012 re-read 3 minutes ago

Autologous Stem Cells (CD34+)

Cell therapy

Developed for
intermittent vascular claudication · peripheral arterial disease

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 1 NCT00311805 Comparator Apr 2006 → Dec 2012 intermittent vascular claudication, peripheral arterial disease Losordo, Douglas, M.D. Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Autologous Stem Cells (CD34+) ClinicalTrials.gov intervention name — accepted as the source's own label NCT00311805 ↗
Modality Cell therapy “Autologous Stem Cells (CD34+)” NCT00311805 ↗
Route Intramuscular “Intramuscular Injections” NCT00311805 ↗